KURA ONCOLOGY, INC. Accumulated Other Comprehensive Income
KURA ONCOLOGY, INC. (KURA) had Accumulated Other Comprehensive Income of $1.02 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent › Accumulated Other Comprehensive Income (Loss), Net of Tax
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-03-05
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.02M.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $711.00K.
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $974.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $764.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | $1.02M 10-K · filed 2026-03-05 |
| 2025-06-30 | $711.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $974.00K 10-Q · filed 2025-05-01 |
| 2024-12-31 | $764.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $1.12M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$463.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$816.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | -$1.27M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$3.54M 10-Q · filed 2023-11-02 |
| 2023-06-30 | -$5.22M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$5.90M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$8.03M 10-K · filed 2024-02-27 |
| 2022-09-30 | -$9.42M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$7.82M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$6.65M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$1.79M 10-K · filed 2023-02-23 |
| 2021-09-30 | -$194.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$393.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | -$82.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $46.00K 10-K · filed 2022-02-24 |
| 2020-09-30 | $224.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $557.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $561.00K 10-Q · filed 2020-05-04 |
| 2019-12-31 | $331.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $332.00K 10-Q · filed 2019-11-05 |
| 2019-06-30 | $161.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $18.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$131.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | -$123.00K 10-Q · filed 2018-11-05 |
| 2018-06-30 | -$93.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | -$68.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$49.00K 10-K · filed 2019-03-05 |
| 2017-09-30 | -$14.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$22.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$19.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$18.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $11.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $45.00K 10-Q · filed 2016-08-10 |
| 2016-03-31 | $11.00K 10-Q · filed 2016-05-11 |
| 2015-12-31 | -$87.00K 10-K · filed 2017-03-14 |
| 2015-09-30 | $1.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | -$14.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |